Routine screening for placenta accreta spectrum.
Placenta accreta spectrum
Placenta previa
Screening
Journal
Best practice & research. Clinical obstetrics & gynaecology
ISSN: 1532-1932
Titre abrégé: Best Pract Res Clin Obstet Gynaecol
Pays: Netherlands
ID NLM: 101121582
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
received:
01
06
2023
revised:
04
07
2023
accepted:
06
07
2023
medline:
11
9
2023
pubmed:
5
8
2023
entrez:
4
8
2023
Statut:
ppublish
Résumé
Screening for clinically significant placenta accreta spectrum (PAS) is possible with a high degree of accuracy (both sensitivity and specificity >90-95%). The group of women to focus on are those with placenta previa and one or more prior Cesarean deliveries. Screening for PAS not associated with placenta previa is not as productive, and several false negatives have been described. The results of the screening program indicate that women have a low or high probability of PAS. Screen-positive women or those with uncertain ultrasound features should be referred to a center of excellence. Those confirmed to have a high probability of PAS should electively be delivered at such centers.
Identifiants
pubmed: 37541113
pii: S1521-6934(23)00100-1
doi: 10.1016/j.bpobgyn.2023.102392
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
102392Informations de copyright
Copyright © 2023 The Author. Published by Elsevier Ltd.. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest Amarnath Bhide authored the guidelines on PAS produced on behalf of the Royal College of Obstetricians and Gynaecologists (RCOG), UK; International Federation of Obstetrics and Gynecology (FIGO); and Society of Maternal and Fetal Medicine (SMFM), USA.